Price movement over the last 24 hours
AdaptHealth Corp vs Progressive Corp — how do they compare? AdaptHealth Corp trades at $10.04 (market cap $1.38B), while Progressive Corp trades at $235 (market cap $136.47B). The key difference: Progressive Corp is far larger — about 98.9× AdaptHealth Corp's market cap, and Progressive Corp pays a 5.93% dividend while AdaptHealth Corp pays none. Which is the better fit depends on your goals.
| AHCO | PGR | |
|---|---|---|
Market Cap | $1.38B | $136.47B |
Sector | Health | Financials |
52-Week High | $13.38 | $252.68 |
52-Week Low | $8.68 | $190.40 |
Enterprise Value | $3.33B | $144.69B |
Dividend Yield | — | 5.93% |
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.
The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.
Progressive (PGR) trades at $234.40, up 0.94% with a bullish technical signal and strong fundamentals. Recent earnings beat expectations with Q1 2026 EPS of $4.96 versus $4.85 estimate, continuing a trend of operational strength. Revenue grew to $87.64B in 2025 with net income margin at 12.93%, while analyst consensus price target is $235.67. The stock shows resilience with positive media coverage highlighting earnings growth and leadership changes.
Outlook remains positive driven by earnings momentum and scale advantages in auto insurance. Key risks include competitive pressures and macroeconomic sensitivity. Institutional sentiment is mixed with 41.46% buy ratings, but the stock's valuation at P/E 11.78 offers room for upside if earnings trends persist.
Trailing returns across standard periods
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →Progressive underwrites private and commercial auto insurance and specialty lines
Read more on PGR →